Literature DB >> 24080167

Novel intergenotype human norovirus recombinant GII.16/GII.3 in Bangladesh.

Shamsun Nahar1, Mokibul Hassan Afrad, Jelle Matthijnssens, Mohammed Ziaur Rahman, Zehadee Momtaz, Rahena Yasmin, Mohammad Jubair, Abu Syed Golam Faruque, Mohammad Sahabuddin Kabir Choudhuri, Tasnim Azim, Mustafizur Rahman.   

Abstract

Noroviruses (NoVs) are one of the major etiological agents of acute gastroenteritis in all age groups. In this study, we identified an intergenotype NoV recombinant strain in the fecal specimens of two male infants with acute diarrhea in Bangladesh. Phylogenetic analysis showed that the identified strains were recombinant NoV strains with a GII.3 capsid and a GII.16 polymerase gene. The recombination breakpoint was located in the ORF1/ORF2 overlap region. To the best of our knowledge this is the first report of a NoV recombinant GII.16/GII.3 strain worldwide.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bangladesh; Diarrhea; GII.16; GII.3; Norovirus; Recombinant

Mesh:

Substances:

Year:  2013        PMID: 24080167     DOI: 10.1016/j.meegid.2013.09.021

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  8 in total

1.  Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant Viruses.

Authors:  Jennifer L Cannon; Leslie Barclay; Nikail R Collins; Mary E Wikswo; Christina J Castro; Laura Cristal Magaña; Nicole Gregoricus; Rachel L Marine; Preeti Chhabra; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

2.  Hospital-based Surveillance for Pediatric Norovirus Gastroenteritis in Bangladesh, 2012-2016.

Authors:  Syed M Satter; Zarin Abdullah; Cristina V Cardemil; Meerjady S Flora; Emily S Gurley; Mahmudur Rahman; Muhammad Talha; Md D Islam; Mohammad E Hossain; Neha Balachandran; Benjamin Lopman; Mustafizur Rahman; Jan Vinjé; Aron J Hall; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2021-03-01       Impact factor: 3.806

3.  Complete Genome Sequence of a Recombinant GII.P16-GII.4 Norovirus Detected in Kawasaki City, Japan, in 2016.

Authors:  Yuki Matsushima; Tomomi Shimizu; Mariko Ishikawa; Ayako Komane; Nobuhiko Okabe; Akihide Ryo; Hirokazu Kimura; Kazuhiko Katayama; Hideaki Shimizu
Journal:  Genome Announc       Date:  2016-10-06

4.  Detection and molecular characterization of the novel recombinant norovirus GII.P16-GII.4 Sydney in southeastern Brazil in 2016.

Authors:  Débora Maria Pires Gonçalves Barreira; Túlio Machado Fumian; Marco André Loureiro Tonini; Lays Paula Bondi Volpini; Rodrigo Pratte Santos; Anézia Lima Chaves Ribeiro; José Paulo Gagliardi Leite; Márcia Terezinha Baroni de Moraes E Souza; Patrícia Brasil; Denise Cotrim da Cunha; Marize Pereira Miagostovich; Liliana Cruz Spano
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

5.  Genotypes, recombinant forms, and variants of norovirus GII.4 in Gipuzkoa (Basque Country, Spain), 2009-2012.

Authors:  Ainara Arana; Gustavo Cilla; Milagrosa Montes; María Gomariz; Emilio Pérez-Trallero
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

6.  Novel norovirus recombinants detected in South Africa.

Authors:  Janet Mans; Tanya Y Murray; Maureen B Taylor
Journal:  Virol J       Date:  2014-09-17       Impact factor: 4.099

7.  Norovirus Recombinant Strains Isolated from Gastroenteritis Outbreaks in Southern Brazil, 2004-2011.

Authors:  Tulio Machado Fumian; Juliana da Silva Ribeiro de Andrade; José Paulo Gagliardi Leite; Marize Pereira Miagostovich
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

8.  Genetic characterization and evolutionary analysis of norovirus genotypes circulating among children in eastern India during 2018-2019.

Authors:  Mahadeb Lo; Suvrotoa Mitra; Papiya De; Anindita Banerjee; Alok Kumar Deb; Shin-Ichi Miyoshi; Asis Manna; Sanat Kumar Ghosh; Keinosuke Okamoto; Shanta Dutta; Mamta Chawla-Sarkar
Journal:  Arch Virol       Date:  2021-08-12       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.